Beto O'Rourke spent his 50th birthday this week behind the wheel of his pickup in Texas, fast approaching a big moment in his uphill climb for governor. He is still trying to close in on Gov. Abbott with six weeks until Election Day, Nov. 8.
Just as he did in his , O'Rourke has spent months visiting nearly every corner of the almost 800-mile-wide state, driving into the most strongly Republican counties in an effort to weaken the wall of rural support that has helped the GOP offset losses in booming big cities and suburbs.
In the aftermath of the Uvalde shooting, O'Rourke has called to raise minimum age to purchase such weapons to 21, something Abbott “If Beto can coax Abbott into a moment where there's a stark difference on, say, gun control I think that can have a big impact,” said Jason Villalba, a former Republican state lawmaker. “But to do that you have to be aggressive and take large risks."
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Vote Early Day is October 28th, 2022 - Vote Early DayI’m not 𝒋𝒖𝒔𝒕 voting early because AdamAJRbrothers encouraged us to — but it sure doesn’t hurt 😏 Go to and start making a plan NOW to cast your ballot for the 2022 midterm elections.
続きを読む »
Best Prime Day Apple deals 2022: New deals for Prime Early Access Sale?Amazon Prime Day is over, but with the new Amazon Prime Early Access Sale coming, the deals aren't over. Will there be Apple deals?
続きを読む »
Ubisoft Has Pushed Back Skull & Bones To Early 2023Ubisoft has announced this morning that they are officially punishing the release of SkullAndBones back into Early 2023.
続きを読む »
‘Exceptional’ fossil suggests early birds were brainyA remarkably preserved bird skull unearthed in Brazil contains impressions of advanced brain structures, suggesting early birds were bright like modern ones.
続きを読む »
Biogen stock increases as Alzheimer's drug shows promise in early results of studyEisai announced results from a global study of nearly 1,800 people with early-stage Alzheimer’s. The drugmaker said early results showed that its treatment, lecanemab, reduced patient clinical decline by 27% when compared to a placebo or fake drug after 18 months of the infused treatment.
続きを読む »
Alzheimer's drug shows promise in early results of studyJapan's Eisai Co. said early results showed that its treatment, lecanemab, reduced patient clinical decline by 27% when compared to a placebo or fake drug after 18 months of the infused treatment. abc15
続きを読む »